In our new research https://t.co/5r6eC92aND we found that a low level of CD68+ and CD163+ cells had a negative effect on PFS in patients with r/r cHL, while a low level of M2 (CD163/c-maf+) macrophages improved the prognosis of patients during #nivolumab therapy.
#GeneTherapy for Hurler Syndrome, outstanding work by SR-TIGET and a new hope for patients.
@NEJM @Telethonitalia @SanRaffaeleMI https://t.co/yMdRv70rli
1. All-nonviral editing of T cells+HSPCs came out of academia (26121415; 26216948).
2. So did the Cas-driven mapping of the hotspot for SCD/thal treatment (26375006).
1+2=biotech clin trial success
Health justice here is not an "academic" exercise - hence @igisci focus on this.
Wk 4 @berkeleyMCB graduate class on "Impactful CRISPR": functional genomics for target ID (aka screening) in cancer.
Why this paper:
1. I asked screening KOLs (@JohnDoench + Luke Gilbert) to nominate one.
2. Shows that doing this right is a lot of work.
https://t.co/TYN20Duj7T
Join us TODAY at our @_BSGCT online seminar
We have Prof. Luigi Naldini @NaldiniLab talking about "Advanced genetic engineering of hematopoiesis"
No registration required - join us using this YouTube live link - https://t.co/HASVYxIUVK
2-3pm BST / 3-4pm CET
See you there!!!
Got “behind the scene” tour with my favorite jokey. Ellen was my leukemia attending when I was a fellow at @sloan_kettering. Three decades later she is as brilliant and warm as ever! #ForEverYoung
Register on https://t.co/qcXcdKdwH8
Full program of CGTD is available here https://t.co/lkulgTPnfB
Full program of XV RGMM is available here https://t.co/xRLqpDtYva
#HK and #SA already in!
Please, feel free to describe the IFI diagnostic capacity in your country here:
https://t.co/oTxO9BN5BI
We look still for colleagues from
🇦🇫🇦🇲🇧🇭🇧🇹🇧🇳🇰🇭🇬🇪🇯🇴🇰🇿🇰🇬🇱🇦🇲🇴🇲🇻🇲🇳🇲🇲🇰🇵🇵🇸🇵🇭🇸🇾🇹🇯🇹🇱🇹🇲🇦🇪🇾🇪
And please, disseminate🙏🔁
Register on https://t.co/WIs2tj4gkD
Full program of CGTD is available here https://t.co/KiDdWYTenm
Full program of XV RGMM is available here https://t.co/re7YWFlmmG
"Role and Modulation of #NKCells in #MultipleMyeloma"👉https://t.co/7x5OibfC5O
Another paper in Special Issue: #Immunotherapy in #Myeloma: A Theme Issue in Honor of Prof. Dr. Gösta Gahrton https://t.co/8D2OZijeA4 @KrogerNicolaus
@TheEBMT
One step back in order to take big steps forward.
A memoriam episode of our podcast with historical footage of early @TheEBMT meetings, a conversation about Russian pioneer Boris Afanasyev and transplants in Russia.
https://t.co/mOtZZWaqIs
#bmtsm